Betsy Yosia Nadeak
Universitas Sumatera Utara

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

THE SELECTION OF MOISTURIZER FOR TREATMENT OF ATOPIC DERMATITIS Betsy Yosia Nadeak; I Made Birawan
Al-Iqra Medical Journal : Jurnal Berkala Ilmiah Kedokteran Vol 5, No 1 (2022): ILMU KEDOKTERAN
Publisher : Journal Medical Universitas muhammadiyah Makassar

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.26618/aimj.v5i1.7690

Abstract

Atopic Dermatitis (AD) is a chronic inflammatory skin disease that is followed by itching, and affects certain part of a body, especially in the face of  infants (infantile phase) and flexural extremities part (in childhood). The etiology of AD is multifactorial such as skin barrier defects, genetics, immune dysregulation, and environment. Atopic Dermatitis management includes skincare and prevention of recurrence. Moisturizers have been shown have an important role in preventing inflammation of the skin, repairing the skin barrier, and also routine use of moisturizer can reduce the amount of topical corticosteroids used. Currently, the use of moisturizers is one of the standard treatments in AD. This paper will explain the role and formulation of moisturizers so that it can help health workers in determining the choice of moisturizer in AD.
A CUTANEOUS ADVERSE EFFECTS IN COVID-19 VACCINE Betsy Yosia Nadeak; Keneyzia Carla Gliselda; Larasati Budiyarto; Fredric Zulkifly
Unram Medical Journal Vol 11 No 4 (2022): volume 11 no 4
Publisher : Faculty of Medicine Universitas Mataram

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29303/jku.v11i4.777

Abstract

In March 2020, the World Health Organization (WHO) declared COVID-19 as a Pandemic. Vaccines are biological products that can be used to induce the body's immune response which can provide protection against infection and/or disease upon exposure to pathogens. As such, vaccination becomes one of the key roles to prevent the spreading of COVID-19. Based on the results of clinical trials, COVID-19 vaccine shows adequate levels of immunogenicity with various levels of effectiveness and acceptable level of safety. With vaccinations being implemented worldwide, side effects ranging from mild to severe have been reported. Understanding mucocutaneousside effects of COVID-19 Vaccine are important, as they can be seen with the naked eye and have the potential to frighten individuals and populations, leading to public reluctance to being vaccinated.